Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy. The news comes just weeks after the drug's original manufacturer launched the reformulated drug, which was previously only available as an injection. The announcement from Hims is the latest example of the company’s efforts to capitalize on obesity drugs like Wegovy, which have shown dramatic success in helping users shed pounds. Novo Nordisk said Thursday it will take legal action against the new pill, which it called unapproved and inauthentic. Hims' new drug is a compounded medication, which means it is not subject to most federal drug regulations.
